# Janssen Biotech, Inc. – FDA Inspection, Oct 26, 2010

Source: https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/537c661b-815e-4e81-b95f-2f837704182d
Source feed: FDA_Inspections

> FDA inspection 685099 of Janssen Biotech, Inc., October 26, 2010. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 685099
- Company Name: Janssen Biotech, Inc.
- Inspection Date: 2010-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1276933 - 2025-07-29](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/0ecc31ca-e799-4909-bfc9-dcdfa484fbf5)
- FDA Inspection 1265723 - 2025-03-10
- FDA Inspection 1077487 - 2018-11-30
- [FDA Inspection 1046499 - 2018-03-05](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/4135886d-b271-492a-8b05-81d78eba721b)
- [FDA Inspection 1031776 - 2017-11-21](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/2f697eb7-fa9a-4da8-b845-2d83b13b09f0)

Company: https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c